Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Refractory / Relapsed AML

Adolfo Diaz Duque, MD, Jasleen Randhawa, MD, Hagop M. Kantarjian, MD, Naveen Pemmaraju, MD, Elias Jabbour, MD, Alessandra Ferrajoli, MD, William G. Wierda, MD PhD, Zeev Estrov, MD, Marina Konopleva, MD PhD, Farhad Ravandi, MBBS, Yesid Alvarado, MD, Varsha Gandhi, PhD, Gautam Borthakur, MD, Jorge E. Cortes

Blood (2014) 124 (21): 3731.

https://doi.org/10.1182/blood.V124.21.3731.3731

Published: 2014

Journal Articles

High Rates of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients

Zaid Al-Kadhimi, MD, Zartash Gul, MD, Wei Chen, PhD, Daryn Smith, Abhinav Deol, MD, Muneer H. Abidi, MD, Lois Ayash, MD, Lawrence G Lum, MD, DSc, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD

Blood (2012) 120 (21): 1951.

https://doi.org/10.1182/blood.V120.21.1951.1951

Published: 2012

Journal Articles

Combination Treatment of Essential Thrombocythemia with Hydroxyurea and Anagrelide

Inhye E. Ahn, MD, Ethan A. Natelson, MD, Lawrence Rice, MD

Blood (2011) 118 (21): 5177.

https://doi.org/10.1182/blood.V118.21.5177.5177

Published: 2011

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma.

Qaiser Bashir, MD, Wei Wei, Alexandre Chiattone, MD, Gabriela Rondon, MD, Simrit Parmar, M.D., Nina Shah, MD, Ernesto Harold Booc, Dinh Yvonne, Qureshi Sofia, Jatin J Shah, MD, Robert Z. Orlowski, MD, PhD, Donna Weber, MD, Richard Champlin, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD

Blood (2010) 116 (21): 4569.

https://doi.org/10.1182/blood.V116.21.4569.4569

Published: 2010

Journal Articles

Laser Transmyocardial Revascularization (TMLR) Combined with Autologous Bone Marrow Cells (ABMC) for Diffuse Coronary Disease (DCD). Results In 19 Cases

Adrian Alegre, Beatriz Aguado, Hematology, Ph, M. Perez Alfonso, Inmunology, C. Muñoz, Inmunology, M. Ortiz de Landázuri, Inmunology, F. Madrid Sanchez, Inmunology, C. Cámara, Hematology, N. García-Fernández, Hematology, Data, Manager, L. Bascones, Hematology, S. Martinez, Hematology, N. García-León, Hematology, M. Roig, Hematology, J. Duarte, Cardivascular, G. Reyes, Cardivascular

Blood (2010) 116 (21): 1181.

https://doi.org/10.1182/blood.V116.21.1181.1181

Published: 2010

Journal Articles

Use of Recombinant Activated Factor VII in Severe Post-Partum Haemorrhage: Data From the Italian Registry. A Multicentric Observational Retrospective Study.

Giovanni Barillari, Maria Grazia Frigo, Maddalena Casarotto, Antonio Farnia, Barbara Massè, Roberto Wetzl, Andrea Bianchin, Andras Rabi, Paolo Malcarne, Samantha Pasca, Enrico Bigotto, Francesco Dentali, MD

Blood (2009) 114 (22): 4434.

https://doi.org/10.1182/blood.V114.22.4434.4434

Published: 2009

Journal Articles

High Expression of Granzymes and Perforin along with Increased T cell Cycling In Vivo Predicts the Development of Opportunistic Infections (OI) Following Unrelated Cord Blood Transplantation (UCBT).

Paul Szabolcs, MD, Young-Ah Lee, Luciana Marti, Melissa Reese, Joanne Kurtzberg, MD

Blood (2004) 104 (11): 2238.

https://doi.org/10.1182/blood.V104.11.2238.2238

Published: 2004

NARROW

A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Refractory / Relapsed AML

High Rates of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients

Combination Treatment of Essential Thrombocythemia with Hydroxyurea and Anagrelide

Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma.

Laser Transmyocardial Revascularization (TMLR) Combined with Autologous Bone Marrow Cells (ABMC) for Diffuse Coronary Disease (DCD). Results In 19 Cases

Use of Recombinant Activated Factor VII in Severe Post-Partum Haemorrhage: Data From the Italian Registry. A Multicentric Observational Retrospective Study.

High Expression of Granzymes and Perforin along with Increased T cell Cycling In Vivo Predicts the Development of Opportunistic Infections (OI) Following Unrelated Cord Blood Transplantation (UCBT).

Email alerts

ASH Publications

American Society of Hematology

A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Refractory / Relapsed AML

High Rates of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients

Combination Treatment of Essential Thrombocythemia with Hydroxyurea and Anagrelide

Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma.

Laser Transmyocardial Revascularization (TMLR) Combined with Autologous Bone Marrow Cells (ABMC) for Diffuse Coronary Disease (DCD). Results In 19 Cases

Use of Recombinant Activated Factor VII in Severe Post-Partum Haemorrhage: Data From the Italian Registry. A Multicentric Observational Retrospective Study.

High Expression of Granzymes and Perforin along with Increased T cell Cycling In Vivo Predicts the Development of Opportunistic Infections (OI) Following Unrelated Cord Blood Transplantation (UCBT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only